NOTCH and EZH2 collaborate to repress PTEN expression in breast cancer

Kyrie Pappas1,2,3,4, Tiphaine C Martin1,2, Andrew L Wolfe1,2,5

  • 1Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Communications Biology
|March 22, 2021
PubMed

Insights

PTEN tumor suppressor transcript is often lost in breast cancer. NOTCH and EZH2 alterations drive PTEN repression, contributing to poor prognosis, but PTEN expression can be restored with inhibitors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Downregulation of the PTEN tumor suppressor transcript is frequent in breast cancer, particularly triple-negative breast cancer (TNBC), and is associated with poor prognosis.
  • PTEN expression is typically decreased in breast tumors compared to adjacent normal tissues, while EZH2 (Enhancer of Zeste Homolog 2) expression is increased.

Purpose of the Study:

  • To investigate the relationship between EZH2, NOTCH signaling, and PTEN expression in breast cancer.
  • To elucidate the mechanism by which PTEN repression occurs and identify potential therapeutic targets.

Main Methods:

  • Comparative analysis of PTEN and EZH2 expression in breast tumors versus normal tissues.
  • Correlation studies of EZH2 and PTEN expression in large breast cancer cohorts.
  • Investigation of NOTCH alterations (mutations, fusions) and their association with EZH2 and PTEN levels.
  • Experimental validation of PTEN repression mechanism involving NOTCH and EZH2.
  • Assessment of therapeutic interventions including EZH2 and gamma-secretase inhibitors, and gene knockdown.

Main Results:

  • PTEN expression is decreased and EZH2 expression is increased in nearly all breast tumors compared to normal ducts.
  • EZH2 inversely correlates with PTEN expression in breast cancer cohorts.
  • NOTCH alterations are frequent in tumors with high EZH2 expression and are associated with decreased PTEN.
  • NOTCH (NOTCH1/2) and EZH2 cooperate to transcriptionally repress PTEN in a subset of breast cancers.
  • PTEN expression can be restored by inhibiting EZH2 or NOTCH signaling pathways.

Conclusions:

  • NOTCH and EZH2 alterations drive PTEN transcriptional repression, contributing to poor prognosis in a subset of breast cancers.
  • Targeting EZH2 or NOTCH signaling pathways represents a potential therapeutic strategy for restoring PTEN expression and improving outcomes in these patients.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not...
4.7K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.8K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.5K
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
37.2K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.0K